Life Sciences

How Did Treeline Bio Raise $1B for Cancer Drug Innovation?
Business How Did Treeline Bio Raise $1B for Cancer Drug Innovation?

What does it take to amass over a billion dollars in funding while barely making a ripple in the public eye, all to combat one of humanity’s deadliest foes—cancer? In a world where biotech startups often clamor for attention with every small win, Treeline Biosciences, based in Watertown, Mas

How Can Rapid Testing Combat Antibiotic Resistance?
Care How Can Rapid Testing Combat Antibiotic Resistance?

What happens when the very drugs meant to heal become a hidden threat to humanity’s future? Each year in the United States, nearly 3 million infections defy standard antibiotics, claiming over 35,000 lives, and this silent epidemic, fueled by overprescribing in high-pressure settings like urgent c

FDA Fast Tracks Stenoparib for Advanced Ovarian Cancer
Public Policy FDA Fast Tracks Stenoparib for Advanced Ovarian Cancer

Introduction to a Critical Health Challenge Imagine a diagnosis that strikes over 19,000 women annually in the United States, often detected at a stage where options are limited and outcomes uncertain, making it a pressing public health concern. Ovarian cancer remains one of the deadliest

AI-Powered NLP Transforms Healthcare and Life Sciences
Business AI-Powered NLP Transforms Healthcare and Life Sciences

In an era where healthcare systems grapple with an overwhelming deluge of unstructured data—think millions of clinical notes, patient records, and genomic sequences—AI-powered Natural Language Processing (NLP) emerges as a game-changing solution that is revolutionizing how medical professionals ope

FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks
Public Policy FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks

What happens when a long-awaited solution to a debilitating disease turns into a potential threat? In a stunning turn of events, the U.S. Food and Drug Administration (FDA) has suspended the license of Ixchiq, the first chikungunya vaccine approved in the U.S., developed by Valneva, a France-based

America’s Big Bet on GLP-1 Drugs Needs Personalization
Care America’s Big Bet on GLP-1 Drugs Needs Personalization

In a landscape where healthcare costs are soaring and chronic conditions like obesity and type 2 diabetes continue to burden millions, the United States has placed a massive financial wager on GLP-1 receptor agonists, a class of medications heralded for their potential to transform metabolic

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later